Literature DB >> 22302622

The clinical spectrum of juvenile idiopathic arthritis in a large urban population.

Melissa S Tesher1, Karen B Onel.   

Abstract

Urban populations present particular challenges for medical providers. Patients are extremely diverse, with varied socioeconomic, cultural, and ethnic backgrounds. Physicians caring for children with juvenile idiopathic arthritis must be prepared to interact effectively with many types of families who bring with them varied experiences and expectations. Pediatric rheumatologists should be familiar with patient characteristics that can influence disease outcomes. Access to care is affected by place of residence, referral delays, parental education, and the child’s insurance status. Patients of different ethnic backgrounds vary in their trust of physicians and health systems. Understanding of risk in medical decision making is influenced by ethnicity as well. Adherence also varies by ethnic group, with African American patients reporting lower adherence than Caucasian patients. Issues of doctor– patient communication and use of complementary and alternative medicine are also affected by cultural factors. Especially for physicians working in a large metropolitan area, an understanding of societal factors influencing patient behavior is essential to provide optimal care for children with juvenile idiopathic arthritis.

Entities:  

Mesh:

Year:  2012        PMID: 22302622     DOI: 10.1007/s11926-012-0237-7

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  20 in total

1.  Trust in physicians and elements of the medical interaction in patients with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Javier P Berrios-Rivera; Richard L Street; Maria G Garcia Popa-Lisseanu; Michael A Kallen; Marsha N Richardson; Namieta M Janssen; Donald M Marcus; John D Reveille; Noranna B Warner; Maria E Suarez-Almazor
Journal:  Arthritis Rheum       Date:  2006-06-15

2.  Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial.

Authors:  Pirjo Tynjälä; Paula Vähäsalo; Maarit Tarkiainen; Liisa Kröger; Kristiina Aalto; Merja Malin; Anne Putto-Laurila; Visa Honkanen; Pekka Lahdenne
Journal:  Ann Rheum Dis       Date:  2011-05-28       Impact factor: 19.103

3.  The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.

Authors:  Ferdinand C Breedveld; Michael H Weisman; Arthur F Kavanaugh; Stanley B Cohen; Karel Pavelka; Ronald van Vollenhoven; John Sharp; John L Perez; George T Spencer-Green
Journal:  Arthritis Rheum       Date:  2006-01

4.  Patient's ethnicity does not influence utilization of effective therapies in rheumatoid arthritis.

Authors:  Dennis C Ang; Harold E Paulus; James S Louie
Journal:  J Rheumatol       Date:  2006-05       Impact factor: 4.666

5.  The clinical application of the biopsychosocial model.

Authors:  G L Engel
Journal:  Am J Psychiatry       Date:  1980-05       Impact factor: 18.112

6.  Delay in access to appropriate care for children presenting with musculoskeletal symptoms and ultimately diagnosed with juvenile idiopathic arthritis.

Authors:  H E Foster; M S Eltringham; L J Kay; M Friswell; M Abinun; A Myers
Journal:  Arthritis Rheum       Date:  2007-08-15

7.  Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial.

Authors:  Paul Emery; Ferdinand C Breedveld; Stephen Hall; Patrick Durez; David J Chang; Deborah Robertson; Amitabh Singh; Ronald D Pedersen; Andrew S Koenig; Bruce Freundlich
Journal:  Lancet       Date:  2008-07-16       Impact factor: 79.321

8.  Predictors of delayed referral to a pediatric rheumatology center.

Authors:  N Tzaribachev; S M Benseler; P N Tyrrell; A Meyer; J B Kuemmerle-Deschner
Journal:  Arthritis Rheum       Date:  2009-10-15

9.  Understanding why rheumatoid arthritis patient treatment preferences differ by race.

Authors:  Florina Constantinescu; Suzanne Goucher; Arthur Weinstein; Wally Smith; Liana Fraenkel
Journal:  Arthritis Rheum       Date:  2009-04-15

10.  Complementary and alternative medicine use in rheumatoid arthritis: an audit of patients visiting a tertiary care centre.

Authors:  Tarique Zaman; Shikhar Agarwal; Rohini Handa
Journal:  Natl Med J India       Date:  2007 Sep-Oct       Impact factor: 0.537

View more
  1 in total

Review 1.  A systematic review of the barriers affecting medication adherence in patients with rheumatic diseases.

Authors:  Hendra Goh; Yu Heng Kwan; Yi Seah; Lian Leng Low; Warren Fong; Julian Thumboo
Journal:  Rheumatol Int       Date:  2017-07-05       Impact factor: 2.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.